BioProcess International Boston

The BioProcess International (BPI) is an annual trade fair and accompanying conference that has established itself as a central meeting point for the biopharmaceutical industry. Organized by Informa Connect, a specialized division of Informa PLC—a global leader in exhibitions and events—the event is exclusively geared toward professionals in biopharmaceutical development and manufacturing, particularly decision-makers at the forefront of technological innovation.

As part of the international BPI event series held across the USA, Europe, and Asia, the Boston edition holds a special place. The city is recognized as a major hub for biotechnology and a global center for life sciences research, academic excellence, and industrial application. The modern Boston Convention & Exhibition Center provides the ideal setting—centrally located, well-connected, and equipped with infrastructure tailored for large-scale scientific events.

BPI covers the entire value chain of biologics manufacturing—from early-stage research to commercial-scale production. Key focus areas include the development of high-performing cell lines, scalable upstream and downstream processes, advanced purification technologies, analytical methods, and regulatory requirements. Emerging therapeutic approaches such as cell and gene therapies are gaining increasing attention. Innovative production methods like continuous biomanufacturing, the use of single-use technologies, and the application of artificial intelligence for process control are shaping the industry’s future. Particular emphasis is placed on the integration of digital solutions—such as digital twins, automated systems, and data-driven process analytics—that are driving the sector toward Industry 4.0.

Another core focus is on novel modalities such as CAR-T cell therapies, mRNA technologies, antibody-drug conjugates (ADCs), and bispecific antibodies, including their scalable and regulatory-compliant manufacturing. The program also offers deep insights into process analytics, quality assurance, and strategic aspects of commercialization, including technology transfer, project management, and supply chain optimization.

The exhibition brings together an international field of participants, including leading biopharma companies, innovative start-ups, service providers, and technology suppliers. Featured solutions range from recombinant proteins and monoclonal antibodies (mAbs) to cell and gene modification tools, single-use systems, and process automation technologies.

A highlight of the event is the presentation of industry awards during “Biotech Week Boston”, which honors outstanding achievements in research, development, and industrial implementation. The program is complemented by a variety of networking formats—including thematic lunch sessions, exclusive receptions, and a festival event at the renowned Museum of Science—designed to foster informal exchange.

BioProcess International in Boston stands for depth of content, topical relevance, and global connectivity. It offers a specialized platform to stay informed about the latest developments, initiate strategic partnerships, and discover concrete solutions to current challenges in biopharmaceutical manufacturing. Its broad thematic scope, international reach, and strong foundation in one of the world’s most dynamic biotech regions make it a unique gathering point for industry professionals.

The BioProcess International will take place on 4 days from Monday, 15. September to Thursday, 18. September 2025 in Boston.